Clinical trial
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With…
NCT00423501 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00423501 |
|---|---|
| Title | A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin. |
| Official title | A Double Blind, Placebo-controlled, Dose-ranging Study to Investigate the Effect on Glycemic Control, Safety, Pharmacokinetics and Pharmacodynamics of GLP-1 in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | Placebo, taspoglutide |
| Enrollment | 306 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 18, 2007 |
| Last update posted | Nov 2, 2016 |
| Countries | Australia, Bulgaria, Germany, Guatemala, Hong Kong, Latvia, Lithuania, Mexico, Romania, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: